BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab)
/PRNewswire/ -- BJ Bioscience, Inc. BJ Bioscience, a biotech company focusing on discovery and development of novel biologics for cancer immunotherapy, today...
United States Joe Zhang Prnewswire Bj Bioscience Inc Merck Co Inc Source Bj Bioscience Inc Merck Sharp Dohme
Source: prnewswire.com